Mihai Lupu Selected Research

Mihai Lupu Research Topics

Disease

12	Neoplasms (Cancer) 04/2023 - 01/2016
7	Melanoma (Melanoma, Malignant) 05/2021 - 01/2016
4	Inflammation (Inflammations) 01/2023 - 01/2016
3	Basal Cell Carcinoma (Rodent Ulcer) 01/2023 - 01/2016
3	Heart Failure 01/2023 - 01/2019
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020 - 01/2016
3	Skin Neoplasms (Skin Cancer) 01/2020 - 01/2016
2	Heart Diseases (Heart Disease) 12/2022 - 01/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2022 - 01/2019
2	Acne Vulgaris 11/2022 - 11/2020
1	Actinic Keratosis 01/2024
1	Amyloid Plaque 01/2023
1	Cardiomegaly (Heart Hypertrophy) 01/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Hypertrophy 01/2023
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2023
1	Atherosclerosis 12/2022
1	Myocardial Infarction 12/2022
1	Stroke (Strokes) 12/2022
1	Acute Disease 12/2022
1	Necrosis 12/2022
1	Mouth Neoplasms (Oral Cancer) 09/2021
1	Margins of Excision 01/2021
1	Iron Deficiencies 01/2019
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2018
1	Squamous Cell Carcinoma of Head and Neck 01/2018
1	Hemangioma (Angioma) 01/2018
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018
1	Carcinoma (Carcinomatosis) 01/2016
1	Cicatrix (Scar) 01/2016
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2016
1	Carcinogenesis 01/2016
1	Kidney Neoplasms (Kidney Cancer) 01/2016
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2016
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2016
1	Lymphoma (Lymphomas) 01/2016

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 09/2021 - 01/2016
3	IronIBA 01/2023 - 01/2019
2	CollagenIBA 04/2023 - 04/2019
2	NeuropeptidesIBA 05/2021 - 01/2018
2	Celecoxib (Celebrex)FDA Link 04/2021 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2016
2	ProteomeIBA 01/2016 - 01/2016
1	MucinsIBA 01/2023
1	DeferiproneIBA 01/2023
1	Hydroxy AcidsIBA 11/2022
1	CatecholaminesIBA 05/2021
1	Substance PIBA 05/2021
1	Serotonin (5 Hydroxytryptamine)IBA 05/2021
1	alpha-MSHIBA 05/2021
1	beta-Endorphin (Endorphin, beta)IBA 05/2021
1	CannabinoidsIBA 05/2021
1	EnkephalinsIBA 05/2021
1	Glutamic Acid (Glutamate)FDA Link 05/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 05/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2021
1	Antineoplastic Agents (Antineoplastics)IBA 04/2021
1	trametinibIBA 04/2021
1	Sirolimus (Rapamycin)FDA Link 04/2021
1	Mitogen-Activated Protein KinasesIBA 04/2021
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 04/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 11/2020
1	TOR Serine-Threonine KinasesIBA 11/2020
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2020
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2020
1	Macrophage Migration-Inhibitory FactorsIBA 01/2020
1	3-ingenyl angelateIBA 01/2019
1	Imiquimod (Aldara)FDA LinkGeneric 01/2019
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2019
1	Fluorouracil (Carac)FDA LinkGeneric 01/2019
1	RetinoidsIBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	Inflammation MediatorsIBA 01/2019
1	CytokinesIBA 01/2018
1	Programmed Cell Death 1 ReceptorIBA 01/2018
1	Interleukin-10 (Interleukin 10)IBA 01/2018
1	IpilimumabIBA 01/2018
1	pembrolizumabIBA 01/2018
1	Immunologic Factors (Immunomodulators)IBA 01/2018
1	NivolumabIBA 01/2018
1	AntibodiesIBA 01/2018
1	Monoclonal AntibodiesIBA 01/2018
1	Polytetrafluoroethylene (Teflon)FDA Link 07/2017
1	Arsenicals (Arsenic Compounds)IBA 01/2016
1	InsecticidesIBA 01/2016

Therapy/Procedure

7	Therapeutics 04/2021 - 01/2016
1	Skin Care 01/2024
1	Intravenous Administration 12/2022
1	Mohs Surgery (Mohs' Micrographic Surgery) 01/2021
1	Radiotherapy 01/2018